Market Research Report Tumor Necrosis Factor Receptor Superfamily Member | Page 3

Kyowa Hakko Kirin Co., Ltd. 36
Novartis AG 37
Seattle Genetics, Inc. 38
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or
CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Drug Profiles 39
2C-10 - Drug Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
ABBV-428 - Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
APG-1233 - Drug Profile 41
Product Description 41
Mechanism Of Action 41
R&D Progress 41
APX-005M - Drug Profile 42
Product Description 42
Mechanism Of Action 42
R&D Progress 42
BI-655064 - Drug Profile 44
Product Description 44
Mechanism Of Action 44
R&D Progress 44
bleselumab - Drug Profile 46
Product Description 46
Mechanism Of Action 46
R&D Progress 46
BMS-986090 - Drug Profile 47
Product Description 47
Mechanism Of Action 47
R&D Progress 47
CFZ-533 - Drug Profile 48
Request for Free Sample Report

Product Description 48
Mechanism Of Action 48
R&D Progress 48
FFP-104 - Drug Profile 50
Product Description 50
Mechanism Of Action 50
R&D Progress 50
JNJ-64457107 - Drug Profile 51
Product Description 51
Mechanism Of Action 51
R&D Progress 51
KGYY-15 - Drug Profile 53